Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 22, 2019
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced the pricing of an underwritten public offering of 4,855,341 shares of...
-
May 21, 2019
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced that it intends to offer and sell shares of common stock (or pre-funded...
-
May 13, 2019- Earnings and business update call scheduled for 9:00 am ET today
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the first quarter ended March 31, 2019. CEO, Erez Raphael,...
-
May 7, 2019Earnings Discussion and Business Update Scheduled for 9:00 am EDT
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its first quarter 2019 results on Monday, May 13, and host a conference call the same...
-
May 3, 2019DarioHealth's mission is to support people with diabetes and other chronic conditions in the U.S. and around the world. Dario is proud to align its efforts with those of the American Diabetes Association (ADA) to increase awareness of diabetes and its risk factors, and to support those living with diabetes and their loved ones
Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is partnering with the American Diabetes Association as a Living Red Sponsor of NYC - Step Out®:...
Apr 30, 2019Dario's mission is aligned with the DTA's mission of improving healthcare quality, outcomes, and value through optimizing the use and integration of digital therapeuticsGlobal digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is now a member of the Digital Therapeutics Alliance (DTA) (www.DTxAlliance.org). Dario's...
-
Apr 10, 2019New version V4.2.0 is a testament to Dario's relentless commitment to patients with chronic conditions.
Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced the launch of a new version of its acclaimed Dario® system and DarioEngage™ platform. The enhancements...
-
Apr 1, 2019The 'Per Engaged Member Per Month' (PEMPM) model is value-driven, simple and effective to cover the needs of providers and their patients
Global #digitaltherapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced an agreement with Cupertino-based Auer Integrative Health's Functional Medicine and Chiropractic, a Silicon...
Mar 27, 2019The Dario® Blood Glucose Monitoring System will be made available to hospitals and health systems using Glytec's virtual insulin titration service for outpatients with diabetesGlobal digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for...
-
Mar 25, 2019Conference Call Scheduled for 9:00 am ET today
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the full-year ended on December 31, 2018. Financial Highlights...